Sign in

CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
operating
EIN
383982704
Phone
6096193990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
  1. UPLOAD Other SEC-generated Letter
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-1 Offering Registration Statement
  4. 8-K Event Material agreement · Unregistered share sale
  5. 424B3 Offering Prospectus
  6. EFFECT Other Notice of Effectiveness
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. S-1 Offering Registration Statement
  11. 424B3 Offering Prospectus
  12. 424B3 Offering Prospectus
  13. 10-Q Report Quarterly Report
  14. SC 13G Stake Amended Statement of Ownership
  15. 424B3 Offering Prospectus
  16. 424B3 Offering Prospectus
  17. 8-K Event Shareholder rights changed · Other events
  18. 8-K Event Material agreement
  19. 10-K/A Report 10-K/A
  20. 4 Insider Changes in Ownership

Page 37 of 42 · 833 filings